Earnings History Data for TScan Therapeutics (TCRX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
TScan Therapeutics
TScan Therapeutics Inc. is a biopharmaceutical company. It focused on the development of T-cell receptor engineered T cell therapies for the treatment of patients with cancer. The company's lead product pipeline consist TSC-100 and TSC-101. TScan Therapeutics Inc. is based in WALTHAM, Mass.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12-11-2024 | PM | TCRX | TScan Therapeutics | 306.00 | -0.25 | -0.28 | 0.00 | TScan Therapeutics GAAP EPS of -$0.25, revenue of $1.04M [11/12/2024 9:48 AM] |
5.39 | -0.31 (-5.44%) |
5.74 | 0.04 (0.70%) |
3.73 - 9.69 | 248,408 | 350,000 | 2,853 | ||
| 12-08-2024 | PM | TCRX | TScan Therapeutics | 320.00 | -0.28 | -0.30 | 0.00 | TScan Therapeutics GAAP EPS of -$0.28, revenue of $0.5M [8/12/2024 8:44 AM] |
6.00 | 0.08 (1.35%) |
0.0 | 0.0 (0.00%) |
1.97 - 9.69 | 218,922 | 220,000 | 0 | ||
| 13-05-2024 | PM | TCRX | TScan Therapeutics | 373.00 | -0.32 | -0.25 | 0.00 | TScan Therapeutics GAAP EPS of -$0.32, revenue of $0.56M [5/13/2024 9:19 AM] |
8.00 | 0.27 (3.49%) |
7.70 | -0.03 (-0.39%) |
1.93 - 9.09 | 135,795 | 170,000 | 2,664 | ||
| 06-03-2024 | PM | TCRX | TScan Therapeutics | 341.00 | -0.21 | -0.30 | 0.00 | TScan Therapeutics GAAP EPS of -$0.21, revenue of $7.2M [3/6/2024 9:57 AM] |
7.16 | 0.13 (1.85%) |
0.0 | 0.0 (0.00%) |
1.62 - 7.87 | 128,069 | 160,000 | 0 | ||
| 10-05-2023 | PM | TCRX | TScan Therapeutics | 55.00 | -0.93 | -0.73 | 0.00 | TScan Therapeutics GAAP EPS of -$0.93 misses by $0.19, revenue of $6.81M beats by $2.51M [5/10/2023 1:43 PM] |
5.04 | 1.64 (48.24%) |
4.21 | 0.81 (23.82%) |
1.45 - 6.03 | 17,477,053 | 5,050,000 | 3,121,014 | ||
| 10-08-2022 | PM | TCRX | TScan Therapeutics | 101.00 | -0.63 | -0.76 | 0.00 | TScan Therapeutics GAAP EPS of -$0.63 beats by $0.13, revenue of $4.05M beats by $1.05M [8/10/2022 8:14 AM] |
4.00 | -0.15 (-3.61%) |
0.0 | 0.0 (0.00%) |
1.60 - 14.71 | 12,751 | 30,000 | 0 | ||
| 09-05-2022 | PM | 7:00 AM ET (May 9) |
TCRX | TScan Therapeutics | 44.00 | -0.67 | -0.69 | 0.00 | TScan Therapeutics GAAP EPS of -$0.67 beats by $0.06, revenue of $3.02M beats by $0.26M [5/9/2022 7:52 AM] |
1.65 | -0.15 (-8.61%) |
0.0 | 0.0 (0.00%) |
1.60 - 14.71 | 52,678 | 90,000 | 0 | |
| 10-11-2021 | PM | TCRX | TScan Therapeutics | 204.00 | -0.80 | -0.68 | 0.00 | TScan Therapeutics EPS beats by $0.16, beats on revenue [11/10/2021 9:24 AM] |
8.75 | 0.25 (2.94%) |
0.0 | 0.0 (0.00%) |
6.06 - 14.71 | 8,383 | 20,000 | 0 | ||